Literature DB >> 22009719

Disparities in cancer screening in individuals with a family history of breast or colorectal cancer.

Ninez A Ponce1, Jennifer Tsui, Sara J Knight, Aimee Afable-Munsuz, Uri Ladabaum, Robert A Hiatt, Jennifer S Haas.   

Abstract

BACKGROUND: Understanding racial/ethnic disparities in cancer screening by family history risk could identify critical opportunities for patient and provider interventions tailored to specific racial/ethnic groups. The authors evaluated whether breast cancer (BC) and colorectal cancer (CRC) disparities varied by family history risk using a large, multiethnic population-based survey.
METHODS: By using the 2005 California Health Interview Survey, BC and CRC screening were evaluated separately with weighted multivariate regression analyses, and stratified by family history risk. Screening was defined for BC as mammogram within the past 2 years for women aged 40 to 64 years; for CRC, screening was defined as annual fecal occult blood test, sigmoidoscopy within the past 5 years, or colonoscopy within the past 10 years for adults aged 50 to 64 years.
RESULTS: The authors found no significant BC screening disparities by race/ethnicity or income in the family history risk groups. Racial/ethnic disparities were more evident in CRC screening, and the Latino-white gap widened among individuals with family history risk. Among adults with a family history for CRC, the magnitude of the Latino-white difference in CRC screening (odds ratio [OR], 0.28; 95% confidence interval [CI], 0.11-0.60) was more substantial than that for individuals with no family history (OR, 0.74; 95% CI, 0.59-0.92).
CONCLUSIONS: Knowledge of their family history widened the Latino-white gap in CRC screening among adults. More aggressive interventions that enhance the communication between Latinos and their physicians about family history and cancer risk could reduce the substantial Latino-white screening disparity in Latinos most susceptible to CRC.
Copyright © 2011 American Cancer Society.

Entities:  

Mesh:

Year:  2011        PMID: 22009719      PMCID: PMC3262934          DOI: 10.1002/cncr.26480

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  48 in total

1.  Do HMO market level factors lead to racial/ethnic disparities in colorectal cancer screening? A comparison between high-risk Asian and Pacific Islander Americans and high-risk whites.

Authors:  Ninez A Ponce; Soonim Huh; Roshan Bastani
Journal:  Med Care       Date:  2005-11       Impact factor: 2.983

2.  Disparities in colorectal cancer screening: a guideline-based analysis of adherence.

Authors:  Tamarra M James; K Allen Greiner; Edward F Ellerbeck; Changyong Feng; Jasjit S Ahluwalia
Journal:  Ethn Dis       Date:  2006       Impact factor: 1.847

3.  Validation of family history of breast cancer and identification of the BRCA1 and other syndromes using a population-based cancer registry.

Authors:  H Anton-Culver; T Kurosaki; T H Taylor; M Gildea; D Brunner; D Bringman
Journal:  Genet Epidemiol       Date:  1996       Impact factor: 2.135

4.  A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey.

Authors:  David A Etzioni; Ninez A Ponce; Susan H Babey; Benjamin A Spencer; E Richard Brown; Clifford Y Ko; Neetu Chawla; Nancy Breen; Carrie N Klabunde
Journal:  Cancer       Date:  2004-12-01       Impact factor: 6.860

5.  Perceived risk of breast cancer among women at average and increased risk.

Authors:  Jennifer S Haas; Celia P Kaplan; Genevieve Des Jarlais; Virginia Gildengoin; Eliseo J Pérez-Stable; Karla Kerlikowske
Journal:  J Womens Health (Larchmt)       Date:  2005-11       Impact factor: 2.681

6.  Factors associated with colon cancer screening: the role of patient factors and physician counseling.

Authors:  Christina C Wee; Ellen P McCarthy; Russell S Phillips
Journal:  Prev Med       Date:  2004-12-29       Impact factor: 4.018

7.  Breast cancer screening behaviors among African American women with a strong family history of breast cancer.

Authors:  Chanita Hughes Halbert; Lisa Kessler; E Paul Wileyto; Benita Weathers; Jill Stopfer; Susan Domchek; Aliya Collier; Kiyona Brewster
Journal:  Prev Med       Date:  2006-07-24       Impact factor: 4.018

8.  Does utilization of screening mammography explain racial and ethnic differences in breast cancer?

Authors:  Rebecca Smith-Bindman; Diana L Miglioretti; Nicole Lurie; Linn Abraham; Rachel Ballard Barbash; Jodi Strzelczyk; Mark Dignan; William E Barlow; Cherry M Beasley; Karla Kerlikowske
Journal:  Ann Intern Med       Date:  2006-04-18       Impact factor: 25.391

9.  Accuracy of reports of familial breast cancer in a case-control series.

Authors:  M E Parent; P Ghadirian; A Lacroix; C Perret
Journal:  Epidemiology       Date:  1995-03       Impact factor: 4.822

10.  Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention.

Authors:  Scott D Ramsey; Paula Yoon; Ramal Moonesinghe; Muin J Khoury
Journal:  Genet Med       Date:  2006-09       Impact factor: 8.822

View more
  16 in total

1.  Perceived risk for breast cancer and its relationship to mammography in Blacks, Hispanics, and Whites.

Authors:  Heather Orom; Marc T Kiviniemi; Vickie L Shavers; Levi Ross; Willie Underwood
Journal:  J Behav Med       Date:  2012-07-08

2.  Colorectal cancer knowledge and screening adherence among low-income Hispanic employees.

Authors:  Judy Y Ou; Echo L Warner; Gina E Nam; Laura Martel; Sara Carbajal-Salisbury; Vicky Fuentes; David W Wetter; Anne C Kirchhoff; Deanna Kepka
Journal:  Health Educ Res       Date:  2019-08-01

3.  Racial and ethnic variations in the effects of family history of colorectal cancer on screening compliance.

Authors:  Molly Perencevich; Rohit P Ojha; Ewout W Steyerberg; Sapna Syngal
Journal:  Gastroenterology       Date:  2013-06-22       Impact factor: 22.682

4.  Non-normal Screening Mammography Results, Lumpectomies, and Breast Cancer Reported by California Women, 2001-2009.

Authors:  Veronica L Irvin; Nancy Breen; Helen I Meissner; Benmei Liu; Robert M Kaplan
Journal:  Womens Health Issues       Date:  2015-06-09

5.  Optimism and barriers to colonoscopy in low-income Latinos at average risk for colorectal cancer.

Authors:  Elizaveta Efuni; Katherine N DuHamel; Gary Winkel; Tatiana Starr; Lina Jandorf
Journal:  Psychooncology       Date:  2014-12-19       Impact factor: 3.894

6.  Racial and Ethnic Disparities in Colonoscopic Examination of Individuals With a Family History of Colorectal Cancer.

Authors:  Christopher V Almario; Folasade P May; Ninez A Ponce; Brennan M R Spiegel
Journal:  Clin Gastroenterol Hepatol       Date:  2015-02-28       Impact factor: 11.382

7.  Analyzing Factors of Breast Cancer Screening Adherence among Korean American Women Using Andersen's Behavioral Model of Healthcare Services Utilization.

Authors:  Seok Won Jin; Hee Yun Lee; Jongwook Lee
Journal:  Ethn Dis       Date:  2019-06-13       Impact factor: 1.847

8.  What does Medicaid expansion mean for cancer screening and prevention? Results from a randomized trial on the impacts of acquiring Medicaid coverage.

Authors:  Bill J Wright; Alison K Conlin; Heidi L Allen; Jennifer Tsui; Matthew J Carlson; Hsin Fang Li
Journal:  Cancer       Date:  2015-12-09       Impact factor: 6.860

9.  Associations among family history of cancer, cancer screening and lifestyle behaviors: a population-based study.

Authors:  Georgiana Bostean; Catherine M Crespi; William J McCarthy
Journal:  Cancer Causes Control       Date:  2013-05-17       Impact factor: 2.506

Review 10.  Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review.

Authors:  Jan T Lowery; Dennis J Ahnen; Paul C Schroy; Heather Hampel; Nancy Baxter; C Richard Boland; Randall W Burt; Lynn Butterly; Megan Doerr; Mary Doroshenk; W Gregory Feero; Nora Henrikson; Uri Ladabaum; David Lieberman; Elizabeth G McFarland; Susan K Peterson; Martha Raymond; N Jewel Samadder; Sapna Syngal; Thomas K Weber; Ann G Zauber; Robert Smith
Journal:  Cancer       Date:  2016-06-03       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.